Our passion for innovation—and commitment to help healthcare providers enhance hospital efficiency and patient care around the world—drives us to set new standards in Specialized Diagnostics.
In everything we do, we use our passion and long-term vision to develop meaningful innovations that truly enhance patient care and help create healthier societies worldwide.
Innovative solutions for Laboratory and Point-of-Care testing
For Hemostasis, Acute Care and Autoimmune Diagnostic testing in Central, Satellite and Commercial Laboratories, we offer a comprehensive portfolio of product solutions. And, when it comes to point-of-care testing, our simple, fast and integrated systems facilitate lab management throughout the hospital with connectivity and compliance support—all backed by best-in-class customer service.
Clinical areas of expertise
Leading Hemostasis testing in the lab and at the point of care.
Our Hemostasis product portfolio comprises in vitro diagnostic systems, reagents, data management solutions, automation, and service, used to diagnose and guide treatment of thrombotic and bleeding disorders. Ultimately, Werfen’s Hemostasis solutions improve the quality of patient care, lower costs, and assure regulatory compliance in the clinical laboratory.
Integrative solutions at the speed of life.
From cardiovascular operating rooms and catheterization labs, to intensive care units and emergency departments, Werfen’s Acute Care Diagnostic solutions are integrated and comprehensive. This whole blood testing portfolio line helps clinicians and laboratorians save time, lower costs, assure regulatory compliance and improve patient outcomes.
Ensuring transfusion compatibility, with accuracy and efficiency.
Offering the broadest range of manual and automated solutions, our Transfusion portfolio delivers results accurately, efficiently and productively. A comprehensive line of serology reagents, fully automated instrumentation, industry-leading data management software and molecular products, help ensure donor-recipient compatibility for those in need of a lifesaving blood transfusion.
Advancing diagnostic capabilities in Autimmunity.
Through a dedicated focus on in vitro diagnostics and lab automation for Autoimmunity, our highly accurate reagents and automated systems are designed to serve labs of all sizes. Werfen’s solutions help improve the way patients with Autoimmune diseases are diagnosed, monitored, and treated.
Compatibility solutions supporting new beginnings for patients with transplants.
Featuring molecular and antibody-based assays and software for specialized HLA testing, our Transplant products are used to determine pretransplant compatibility between donors and recipients, and for post-transplant monitoring. By providing high-quality assays, accurate test results, and innovative tools, we can help change the practice of transplant medicine.
Our Latest Innovations
Introducing the GEM Premier 7000 with iQM3 a breakthrough in blood gas testing: hemolysis detection. In a transformative step toward enhancing patient outcomes in acute care, GEM Premier 7000 with iQM3 provides lab-quality detection of hemolysis, in whole blood.
HemoCell Specialized Lab Automation automates the entire Hemostasis testing workflow, enhancing quality and efficiency in your lab. Featuring the ACL TOP 750 LAS and HemoHub Intelligent Data Manager, it’s the only workcell to combine the leading Hemostasis testing system with specialized lab automation. And, customized to your lab’s specific needs, HemoCell is designed to provide the automation right for you.
Lead your lab to the forefront of Autoimmune diagnostics
Realize the full potential of multi-analyte testing with Aptiva’s Particle-based Multi-Analyte Technology (PMAT). With Aptiva®, streamline your workflow, deliver excellent clinical performance and diagnostic confidence.
ROTEM sigma is an easy-to-use, cartridge based viscoelastic testing system that delivers rapid results at the point of care (POC) to guide bleeding management. Used to assess critical bleeding situations, ROTEM TEMograms provide clear, real-time clinical information, enabling clinicians to optimize hemostasis while minimizing blood loss and blood-product exposure—key goals of Patient Blood Management (PBM) programs.
Werfen at a glance
Werfen is a growing, family-owned, innovative company founded in 1966 in Barcelona, Spain.
We are a worldwide leader in specialized diagnostics in the areas of Hemostasis, Acute Care Diagnostics, Transfusion, Autoimmunity, and Transplant. Through our Original Equipment Manufacturing (OEM) business line, we research, develop, and manufacture customized assays and biomaterials.
We operate directly in 30 countries, and in more than 100 territories through distributors. Our Headquarters and Technology Centers are located in the US and Europe. Worldwide sales exceed €1.84 billion in 2022, and our workforce is more than 7,000 strong.